Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Battle lines are drawn as the global health community prepares to face off with Big Pharma over the astronomic cost of treatment.
I am outraged that Gilead refuses to study 7977 with other DAAs that are farther along than their own drugs.
To the tune of $11 billion, Gilead Sciences—a leader in HIV drug development and sales—has acquired one of the most talked-about p...
A twelve-week course of Pharmasset’s once-daily experimental nucleotide analog PSI-7977, combined with ribavirin, cured 10 of 10 people living...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.